| Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia RJ Kreitman, C Dearden, PL Zinzani, J Delgado, L Karlin, T Robak, ... Leukemia 32 (8), 1768-1777, 2018 | 255 | 2018 |
| Safety and efficacy of durvalumab and tremelimumab alone or in combination in patients with advanced gastric and gastroesophageal junction adenocarcinoma RJ Kelly, J Lee, YJ Bang, K Almhanna, M Blum-Murphy, DVT Catenacci, ... Clinical Cancer Research 26 (4), 846-854, 2020 | 99 | 2020 |
| A proportional hazards regression model for the subdistribution with covariates‐adjusted censoring weight for competing risks data P He, F Eriksson, TH Scheike, MJ Zhang Scandinavian Journal of Statistics 43 (1), 103-122, 2016 | 53 | 2016 |
| CD23 expression in follicular lymphoma: clinicopathologic correlations H Olteanu, TS Fenske, AM Harrington, A Szabo, P He, SH Kroft American journal of clinical pathology 135 (1), 46-53, 2011 | 45 | 2011 |
| A re-formulation of generalized linear mixed models to fit family data in genetic association studies T Wang, P He, KW Ahn, X Wang, S Ghosh, P Laud Frontiers in Genetics 6, 120, 2015 | 16 | 2015 |
| Safety and efficacy of durvalumab in combination with tremelimumab, durvalumab monotherapy, and tremelimumab monotherapy in patients with advanced gastric cancer. RJ Kelly, J Lee, YJ Bang, K Almhanna, MA Blum Murphy, DVT Catenacci, ... Journal of Clinical Oncology 36 (15_suppl), 4031-4031, 2018 | 14 | 2018 |
| An interim sample size recalculation for observational studies S Tarima, P He, T Wang, A Szabo Observational Studies 2 (1), 65-85, 2016 | 5 | 2016 |
| Moxetumomab pasudotox in heavily pretreated patients with relapsed/refractory hairy cell leukemia: Results of a pivotal international study. RJ Kreitman, C Dearden, PL Zinzani, J Delgado, T Robak, PD Le Coutre, ... Journal of Clinical Oncology 36 (15_suppl), 7004-7004, 2018 | 4 | 2018 |
| Safety and efficacy of durvalumab in combination with tremelimumab in patients with advanced gastric cancer with elevated tumor interferon-gamma gene signature G Ku, J Lee, HJ Lenz, CE Chee, T Omori, KW Lee, Y Chao, D Catenacci, ... CANCER RESEARCH 79 (13), 2019 | 1 | 2019 |
| Abstract CT057: Safety and efficacy of durvalumab in combination with tremelimumab in patients with advanced gastric cancer with elevated tumor interferon-γ gene signature G Ku, J Lee, HJ Lenz, CE Chee, T Omori, KW Lee, Y Chao, D Catenacci, ... Cancer Research 79 (13_Supplement), CT057-CT057, 2019 | | 2019 |
| Moxetumomab pasudotox in heavily pretreated patients with relapsed/refractory hairy cell leukemia: Results of a pivotal international study P le Coutre, M Rummel, RJ Kreitman, C Dearden, PL Zinzani, J Delgado, ... ONCOLOGY RESEARCH AND TREATMENT 41, 252-252, 2018 | | 2018 |
| TECHNICAL REPORT# 61 NOVEMBER 2013 P HE, TH SCHEIKE, M ZHANG | | 2013 |
| TECHNICAL REPORT# 59 MAY 2013 S Tarima, P He, T Wang, A Szabo | | 2013 |
| Internal Pilot Studies: An Annotated Bibliography A Szabo, T Wang, P He, S Tarima clinical trials 9 (1-2), 65-71, 2012 | | 2012 |
| TECHNICAL REPORT# 58 APRIL 2012 S Tarima, P He, T Wang, A Szabo | | 2012 |
